DeviceTalks Weekly

Hosted by Tom Salemi, DeviceTalks Weekly is the foundational podcast for the entire DeviceTalks Podcast Network. The series delivers weekly news, insights, and commentary from MedTech industry leaders, keeping the medical device industry in the know and inspiring medical technology professionals to build better MedTech devices and companies.

Episodes

Ep 70 - How Abbott and Cordis are working to change the interventional vascular business

August 13, 2021 • 63 mins

Let's get interventional. This week, we talk with leaders from Abbott and Cordis about their plans to advance of medtech's stablest business. Duke Rohlen, executive chair, will explain to co-host Tom Salemi why he led the purchase of Cordis from Cardinal. Meanwhile, Dr. Nick West, CMO and DVP of vascular at Abbott, updates Associated Editor Sean Whooley on the Xience pipeline. This week...

Mark as Played

Ep 69 - Why Koya CEO Doraiswamy is tackling lymphedema; Follow Todd Brinton’s unlikely path to Edwards

August 6, 2021 • 64 mins

This week’s episode focuses on the entrepreneurs. We open up with an interview with Andy Doraiswamy, founder and CEO of Koya Medical, a company he founded to help find a therapy for his ailing father. Then we revisit with Dr. Todd Brinton, chief scientific officer and corporate vice president at Edwards. This interview initially ran in May 2020 but we’re playing it again to amplify the u...

Mark as Played

Ep 68 - What's next in Diabetes? CeQur moving toward manufacturing, Medtronic readying for the long haul

July 30, 2021 • 79 mins

This week's episode focuses on new hope for people with diabetes. Brad Paddock, CEO of CeQur, explains how its "wearable pen" can deliver insulin in a better way while Sean Salmon, head of Medtronic's diabetes business, reviews that company's growing portfolio. He also gives insights on its intriguing partnership with the private equity group, Blackstone. Chris Newmarker, executive edit...

Mark as Played

Ep 67 - Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine

July 23, 2021 • 42 mins

The bioelectronics industry is poised to take off so we visited with Carolina Aguilar, CEO/Co-founder, INBRAIN Neuroelectronics about the field's potential. Chris Newmarker, executive editor of life sciences at MassDevice, delivers his Newmarker's Newsmakers highlighting news from Dexcom, NeuroMetrix, Nevro, Ancora and the Galien foundation. Subscribe to this podcast on Google, Amazon...

Mark as Played

Ep 66 - Hear from the CEOs of two surgical robotics companies that together just raised over $1 billion

July 16, 2021 • 52 mins

Vicarious Surgical and CMR Surgical recently combined to raise over $1 billion from public and private investors. Big money clearly as found surgical robotics. Now what? We connect with Per Vegard Nerseth, the new CEO of CMR. Nerseth comes to CMR from the robotics industry, so he brings deep industry understanding of what it will take to get CMR to the next level. The company closed on ...

Mark as Played

Ep 65 - Leerink sees surge in home dialysis; Vensana, LRV detail deal in CardioDx start-up Cleerly Health

July 9, 2021 • 77 mins

This week we’ll focus on investor insights. First, we’ll talk with Danielle Antalffy, managing director at SVB Leerink. Antalffy covers most of the major medtechs but we’ll focus on a new report she issues on sugaring home-based dialysis business. What does this mean for Outset specifically? More broadly, do other medtechs need to build out their at-home/connectivity function? Also, ...

Mark as Played

Ep 64 - Why Minnetronix made its own medical device. How Cleerly raised $43m to upend Cardiovascular Dx

June 25, 2021 • 63 mins

In this week's DeviceTalks Weekly Podcast, Minnetronix CEO Jeremy Maniak explains how the CMO is using internal know how to develop medical devices that can be sold by outside partners. We also hear from Dr. James Min of Cleerly Health about that company's start and the process that went into raising $43 million. Chris Newmarker, executive editor of life sciences at MassDevice, is back ...

Mark as Played

Ep 63 - How Arboretum Venture' Walker learned early in her medtech career to not take "No" as an answer

June 18, 2021 • 53 mins

Nicole J. Walker, managing partner, Arboretum Ventures, tells a unique medtech story that begins with her sick grandfather and follows up with her refusal to remove her foot from the door at Advanced Cardiovascular Systems. She says she learned early on that she may not always have all the answers when making a decision but she would have the instincts and mettle to push through. This co...

Mark as Played

Ep 62 - Medtronic’s Martha Reviews Year One as CEO: Culture, HeartWare and Giving Meaning to Market Share

June 11, 2021 • 43 mins

A year ago, Geoff Martha took over as CEO of medtech's large single company. With the sector in lockdown, the company still undertook a massive reorganization and moved to adopt a new "Medtronic Mindset" that would favor the bold. In this interview, Martha reviews Year 1, sharing some positive outcomes and disappointments. Chris Newmarker, executive editor of life sciences, delivers h...

Mark as Played

Ep 61 - Can S+N's Aria open up ASC ortho market? Wall Street’s take on Coyle’s departure, Medtronic’s HVAD

June 4, 2021 • 50 mins

In this week’s podcast, Chris Newmarker, executive editor of life sciences, speaks with Laura Rector, Smith + Nephew’s vice president of ambulatory surgery centers and digital health, about the company’s ARIA care management platform. The system uses 3D imaging, artificial intelligence and other tools to help patients recover more quickly from large joint replacement surgery. What’s nex...

Mark as Played

Ep 60 - Makower making medtech innovation bigger, stronger; Medtronic’s Ha speaking up for AAPI colleagues

May 28, 2021 • 62 mins

This week we’ll explore innovation and social equity. First, we’ll hear a portion of an interview with Martha Ha, chief privacy officer and chief counsel of corporate governance, and Jon de Csepel, CMO, vice president, medical affairs of the Americas. The pair will explain how the company is reaching out to employees of Asia and Pacific Island and helping them to understand how to bett...

Mark as Played

Ep 59 - How Atricure built a big business in Afib; A deep look into Abbott's new coronary imaging platform

May 21, 2021 • 58 mins

This week, the DeviceTalks Weekly Podcasts delivers some learning. First, Dr. Nick West, CMO & divisional VP of global medical affairs at Abbott’s vascular business, discusses the European launch of the company's new coronary imaging platform. Dr. West explains how the AI-powered platform works and the benefits it offers for decision-making during coronary stenting procedures. He a...

Mark as Played

Ep 58 - Getting to the heart of Boston Scientific’s peripheral business; How Hologic sees trials changing

May 14, 2021 • 77 mins

Jeff Mirviss, executive vice president of Boston Scientific’s peripheral business, explains why the specialty’s name doesn’t really reflect the importance of arteries, veins and other “highways” that his business group is addressing. Mirviss explains where the peripheral business is headed, and why Boston Scientific is uniquely positioned to address the business. He also shares lessons l...

Mark as Played

Ep 57 - First Mazor, next Hugo - Hear Medtronic's plans to compete in surgical robotics

May 7, 2021 • 48 mins

In this episode, two of the executives leading Medtronic’s push into robotics surgery update listeners on the progress and potential of Medtronic's MAZOR X Stealth and Hugo RAS system platforms. Megan Rosengarten, president of surgical robotics, says HUGO is poised to deliver surgeons newfound capabilities and options. The company hopes to begin selling the system later this year after f...

Mark as Played

Ep 56 - Can Proximie bring safer surgery to the wider world? How is Getinge answering call for ventilators?

April 30, 2021 • 63 mins

Can Proximie bring safer surgery to the wider world? How is Getinge answering call for ventilators? In this week’s podcast senior executives from Getinge and Proximie – two very different sized companies – explain how the COVID-19 pandemic accelerated their business. In the opening keynote conversation, Eric Honroth, president, Getinge North America, explained how the company more than...

Mark as Played

Ep 55 - CEO Mike Coyle sets a strong beat for iRhythm’s future; Introducing new member of podcast family

April 23, 2021 • 57 mins

In this podcast, iRhythm CEO Mike Coyle discusses his decision to join the digital health leader in January. Coyle’s had to hit the ground running as iRhythm manages some challenging decisions from regional Medicare payors but he also sees great opportunity for the company’s ZIO platform across the healthcare spectrum. In this conversation, Coyle discusses • How he came to join the ...

Mark as Played

Ep 54 - How Zimmer Biomet is competing in ortho’s data race; Do medical devices carry physics-based biases?

April 16, 2021 • 56 mins

This week, Liane Teplitsky, vice president and general manager of worldwide robotics at Zimmer Biomet, shares her excitement for the burgeoning data business emerging in orthopedics. Teplitsky, an engineer who built her medtech career in the cardiac R&D and sales at St. Jude and Abbott, walks us through the interconnected offerings of Zimmer’s ZBEdge suite of digital and robotics t...

Mark as Played

Ep 53 - Herrera on how military lessons led to Medtech career; Ulmer ready to redo landmark FDA survey

April 9, 2021 • 73 mins

In this week’s podcast, Derek Herrera explains how a serious battle injury he received while leading Marines in Afghanistan led him to build a career in medtech. Herrera has founded two companies – Spinal Singularity and Habit Camera – to create devices that can improve and save the lives of people who need help the most. Herrera also explains how his military training is serving him so ...

Mark as Played

Ep 52 - Earnhardt shares how Abbott shifted gears to counter pandemic; Grail still looks to upend oncology

April 2, 2021 • 64 mins

This week, we’ll talk with Lisa Earnhardt, executive vice president, medical devices at Abbott about how the life sciences giant pivoted during the pandemic. Earnhardt shares what programs were given greater priority when the impact of the lockdown became clear and why the company performed so well in one of its key businesses. We also explore this week’s news that the FTC will oppose Il...

Mark as Played

Ep 51 - CEO MacMillan on how COVID-19 strengthened Hologic; Startup CEO Jones wins with pitch to help kids

March 26, 2021 • 77 mins

Hologic CEO Steve MacMillan says last March he didn’t appreciate how COVID-19 would change the world forever. But the diagnostics company quickly rose to the challenge, creating one of the surer supplies of diagnostic tools to chart the pandemic's severity. In this DeviceTalks Weekly Podcast, MacMillan shares how Hologic pivoted to meet the calls for help from political leaders in the U...

Mark as Played

Popular Podcasts

24/7 News: The Latest

The latest news in 4 minutes updated every hour, every day.

Crime Junkie

Does hearing about a true crime case always leave you scouring the internet for the truth behind the story? Dive into your next mystery with Crime Junkie. Every Monday, join your host Ashley Flowers as she unravels all the details of infamous and underreported true crime cases with her best friend Brit Prawat. From cold cases to missing persons and heroes in our community who seek justice, Crime Junkie is your destination for theories and stories you won’t hear anywhere else. Whether you're a seasoned true crime enthusiast or new to the genre, you'll find yourself on the edge of your seat awaiting a new episode every Monday. If you can never get enough true crime... Congratulations, you’ve found your people. Follow to join a community of Crime Junkies! Crime Junkie is presented by audiochuck Media Company.

The Clay Travis and Buck Sexton Show

The Clay Travis and Buck Sexton Show. Clay Travis and Buck Sexton tackle the biggest stories in news, politics and current events with intelligence and humor. From the border crisis, to the madness of cancel culture and far-left missteps, Clay and Buck guide listeners through the latest headlines and hot topics with fun and entertaining conversations and opinions.

Stuff You Should Know

If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

The Bobby Bones Show

Listen to 'The Bobby Bones Show' by downloading the daily full replay.

Advertise With Us

DeviceTalks Weekly

Episodes

.css-14f5ked{margin:0;word-break:break-word;display:-webkit-box;-webkit-box-orient:vertical;box-orient:vertical;-webkit-line-clamp:2;overflow:hidden;} Ep 70 - How Abbott and Cordis are working to change the interventional vascular business

.css-r6mb8g{margin:0;word-break:break-word;display:-webkit-box;-webkit-box-orient:vertical;box-orient:vertical;-webkit-line-clamp:1;overflow:hidden;} Ep 69 - Why Koya CEO Doraiswamy is tackling lymphedema; Follow Todd Brinton’s unlikely path to Edwards

Ep 68 - What's next in Diabetes? CeQur moving toward manufacturing, Medtronic readying for the long haul

Ep 67 - Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine

Ep 66 - Hear from the CEOs of two surgical robotics companies that together just raised over $1 billion

Ep 65 - Leerink sees surge in home dialysis; Vensana, LRV detail deal in CardioDx start-up Cleerly Health

Ep 64 - Why Minnetronix made its own medical device. How Cleerly raised $43m to upend Cardiovascular Dx

Ep 63 - How Arboretum Venture' Walker learned early in her medtech career to not take "No" as an answer

Ep 62 - Medtronic’s Martha Reviews Year One as CEO: Culture, HeartWare and Giving Meaning to Market Share

Ep 61 - Can S+N's Aria open up ASC ortho market? Wall Street’s take on Coyle’s departure, Medtronic’s HVAD

Ep 60 - Makower making medtech innovation bigger, stronger; Medtronic’s Ha speaking up for AAPI colleagues

Ep 59 - How Atricure built a big business in Afib; A deep look into Abbott's new coronary imaging platform

Ep 58 - Getting to the heart of Boston Scientific’s peripheral business; How Hologic sees trials changing

Ep 57 - First Mazor, next Hugo - Hear Medtronic's plans to compete in surgical robotics

Ep 56 - Can Proximie bring safer surgery to the wider world? How is Getinge answering call for ventilators?

Ep 55 - CEO Mike Coyle sets a strong beat for iRhythm’s future; Introducing new member of podcast family

Ep 54 - How Zimmer Biomet is competing in ortho’s data race; Do medical devices carry physics-based biases?

Ep 53 - Herrera on how military lessons led to Medtech career; Ulmer ready to redo landmark FDA survey

Ep 52 - Earnhardt shares how Abbott shifted gears to counter pandemic; Grail still looks to upend oncology

Ep 51 - CEO MacMillan on how COVID-19 strengthened Hologic; Startup CEO Jones wins with pitch to help kids

Popular Podcasts

Ep 70 - How Abbott and Cordis are working to change the interventional vascular business

Ep 69 - Why Koya CEO Doraiswamy is tackling lymphedema; Follow Todd Brinton’s unlikely path to Edwards